Molecular Medicine (MLM) Molmed (5 lettori)

Stato
Chiusa ad ulteriori risposte.

smeraldo

Forumer attivo
2.12.4. Zalmoxis – Allogeneic T cells genetically modified with a retroviral vector encoding for a truncated form of the human low affinity nerve growth factor receptor (δlngfr) and the herpes simplex i virus thymidine kinase (hsv-tk mut2); Orphan; EMEA/H/C/002801/R/0003 MolMed SpA; Treatment of adjunctive treatment in haploidentical haematopoietic stem cell transplantation of adult patients with high-risk haematological malignancies Rapporteur: Hans Ovelgönne; CHMP Coordinator: Paula Boudewina van Hennik Scope: 1st annual reassessment for renewal of conditional MA. Opinion Action: for adoption Note: CAT adopted an RSI at is 10-12 April 2017 meeting
 

cloca

voglia di pedalare
2.12.4. Zalmoxis – Allogeneic T cells genetically modified with a retroviral vector encoding for a truncated form of the human low affinity nerve growth factor receptor (δlngfr) and the herpes simplex i virus thymidine kinase (hsv-tk mut2); Orphan; EMEA/H/C/002801/R/0003 MolMed SpA; Treatment of adjunctive treatment in haploidentical haematopoietic stem cell transplantation of adult patients with high-risk haematological malignancies Rapporteur: Hans Ovelgönne; CHMP Coordinator: Paula Boudewina van Hennik Scope: 1st annual reassessment for renewal of conditional MA. Opinion Action: for adoption Note: CAT adopted an RSI at is 10-12 April 2017 meeting

questo è la procedura di rinnovo autorizzazione annuale . zalamoxis
 
Stato
Chiusa ad ulteriori risposte.

Users who are viewing this thread

Alto